ACQUISITION (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 09, 2025 |
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Series E Preferred Stock [Member] | |||
| Business Combination [Line Items] | |||
| Number of shares issued, value | $ 500,000 | ||
| Vector Acquisition [Member] | Stock Purchase Agreement [Member] | |||
| Business Combination [Line Items] | |||
| Acquisition description | Upon closing on September 19, 2025, the Sellers exchanged the Purchased Shares for (i) $500,000 in cash, (ii) 60,000 shares of the Company’s Series E Cumulative Redeemable Secured Preferred Stock (the “Series E Preferred Stock”) with a stated value of $25.00 per share or a total stated value of $1,500,000 (iii) 386,847,195 three year warrants of the Company’s Class A Common Stock with an exercise price of $0.00517 per share (subject to adjustment) (the “Vector Warrants”), which was equal to the closing price of the Company’s Class A Common Stock on the trading day immediately prior to closing, plus 10%, valued at $769,826 and (iv) up to 80,000 shares of Series E Preferred Stock to be issued to the Sellers on or before 120 days after the two-year anniversary of the closing | ||
| Share price | $ 25.00 | ||
| Vector Acquisition [Member] | Stock Purchase Agreement [Member] | Series F Preferred Stock [Member] | |||
| Business Combination [Line Items] | |||
| Number of shares issued, value | $ 4,000,000 | ||
| Number of shares issued | 80,000 | ||
| Vector Acquisition [Member] | Stock Purchase Agreement [Member] | Minimum [Member] | |||
| Business Combination [Line Items] | |||
| Acquisition cost | $ 4,000,000 | ||
| Vector Acquisition [Member] | Stock Purchase Agreement [Member] | Maximum [Member] | |||
| Business Combination [Line Items] | |||
| Acquisition cost | $ 4,000,000 | ||
| Vector [Member] | |||
| Business Combination [Line Items] | |||
| Assets acquired, net of liabilities | $ 700,000 | ||
| Goodwill | 182,831 | ||
| Legal fees | 16,000 | ||
| Vector [Member] | Series E Preferred Stock [Member] | |||
| Business Combination [Line Items] | |||
| Number of shares issued, value | $ 500,000 | ||
| Number of shares issued | 80,000 |
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Description of acquiree in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Includes amount, before amortization expense and impairment loss, of goodwill for private company. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|